SCHEMBL24946356

SCHEMBL24946356

O=C(NC[C@@H]1CCOC1)c1ccc(NC(=O)N2Cc3ccc(Br)cc3C2)cc1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205805 1.00 NAMPT (0.80) NAMPT
SCHEMBL24946362 1.00 NAMPT (0.80) NAMPT
SCHEMBL3709532 0.89 NAMPT (1.00) NAMPT
SCHEMBL3705106 0.89 NAMPT (1.00) NAMPT
SCHEMBL3702316 0.89 NAMPT (1.00) NAMPT
SCHEMBL3696943 0.88 NAMPT (1.00) NAMPT
SCHEMBL3705635 0.88 NAMPT (1.00) NAMPT
SCHEMBL3700500 0.88 NAMPT (1.00) NAMPT
SCHEMBL3700082 0.86 NAMPT (1.00) NAMPT
SCHEMBL3704970 0.83 NAMPT (1.00) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023007147-A1 6-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES THE UNIVERSITY OF MANCHESTER (GB) 2023-02-02 WO disclosed